Skip to content
Disclosery

Founders Fund V Management, LLC

Follow

13F filer, CIK 1697733, SAN FRANCISCO, CA

Founders Fund V Management, LLC reported $1,069,890 across 3 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-25-003331

Period
2025-03-31
Reported value
$1.07M
Holdings
3
Top 10 weight
100%
New
1
Sold out
1

Part of the filer group Founders Fund Growth II Management, LP

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RFLnew+169,451$317K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CYCLO THERAPEUTICS INCexited-480,708-$284K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001085146-25-003331, largest first. % of portfolio is the value over $1,069,890, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RGTIRIGETTI COMPUTING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 88,621 shares; 2024Q2: 88,621 shares; 2024Q3: 88,621 shares; 2024Q4: 88,621 shares; 2025Q1: 88,621 shares 88,621$702K65.6%0Timeline
RFLRAFAEL HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 169,451 shares 169,451$317K29.62%newTimeline
UNITY BIOTECHNOLOGY INC COM…UNITY BIOTECHNOLOGY INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 49,172 shares; 2024Q2: 49,172 shares; 2024Q3: 49,172 shares; 2024Q4: 49,172 shares; 2025Q1: 49,172 shares 49,172$51.1K4.78%0

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CYCLO THERAPEUTICS INCCYCLO THERAPEUTICS INC480,708$284Kshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-25-003331 base2025-05-15acceptance time not in the bulk data set